Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative DNA Methylation Profiling of Human and Murine ALK‐Positive B‐Cell Neoplasms

Genes Chromosomes and Cancer(2025)10.1002/gcc.70060Source: DataRank Database

Comparative DNA Methylation Profiling of Human and Murine ALK‐Positive B‐Cell Neoplasms is a research paper published in Genes Chromosomes and Cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

GEOGSE289985 GSE289988 GSE289990

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: hybridTopics (62)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Rabea Wagener ORCID,Shannon Harkins ORCID,Claudia Voena ORCID,Susanne Bens ORCID,Wolfram Klapper ORCID

Live enrichment

PubMed:40879321 OpenAlex:https://openalex.org/W4412651491

Deutsche Forschungsgemeinschaft

Grant: SFB1074

Deutsche Forschungsgemeinschaft

Grant: SFB1530

National Institutes of Health

Grant: R01 CA196703‐01

NCI NIH HHS

Grant: R01 CA196703

NCI NIH HHS

Grant: P30 CA008748

NIH HHS

Grant: R01 CA196703-01

Deutsche Forschungsgemeinschaft

Grant: 217328187/SFB 1074

Experimental Models and Clinical Translation in Leukemia

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01CA196703-09

Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma

FWCI

0.00

Citation Percentile

0.2%

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/gcc.70060

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/gcc.70060

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.70060

journalhttps://doi.org/10.1002/gcc.70060

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40879321

Fields of Study

Lung Cancer Research StudiesLymphoma Diagnosis and TreatmentCancer Genomics and Diagnostics03 medical and health sciences0302 clinical medicineHumansDNA MethylationAnaplastic Lymphoma KinaseAnimalsMiceLymphoma, Large B-Cell, DiffuseLymphoma, Large-Cell, AnaplasticFemaleMaleAgedMultiple MyelomaMiddle AgedReceptor Protein-Tyrosine Kinases

MeSH Terms

Anaplastic Lymphoma KinaseAgedAnimalsFemaleHumansMaleMiddle AgedMultiple MyelomaLymphoma, Large B-Cell, DiffuseLymphoma, Large-Cell, AnaplasticDNA MethylationReceptor Protein-Tyrosine KinasesMice

Keywords

BiologyDNA methylationDNAMolecular biologyMethylationComputational biologyGeneticsGeneGene expressionTransgenic mouse modelAlk‐positive Lbcls[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologyMale[SDV.MHEP.AHA] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Cancer ResearchTopic 3: Integrative BiomedicineALK‐positive LBCLs; DNA methylation; transgenic mouse modelReceptor Protein-Tyrosine KinasesMiddle AgedArticle[SDV] Life Sciences [q-bio]MiceALK-positive LBCLsHumansAnimalsLymphoma, Large-Cell, AnaplasticAnaplastic Lymphoma KinaseFemaleLymphoma, Large B-Cell, DiffuseMultiple MyelomaAged

Sustainable Development Goals

SDG 0: Life in Land